Copyright
©The Author(s) 2004.
World J Gastroenterol. Dec 1, 2004; 10(23): 3495-3499
Published online Dec 1, 2004. doi: 10.3748/wjg.v10.i23.3495
Published online Dec 1, 2004. doi: 10.3748/wjg.v10.i23.3495
Table 6 Predictive value of positive predictive factors (PPF) for CBD stones and effect of associated other factors, n (%)
| Factor | Alone | One further factor | Two or more further factors |
| Hyperbilirubinaemia | 0/3 | 1/5 (20) | 43/53 (81) |
| Elevated ASAT/ALAT | 1/11 (9) | 13/32 (41) | 60/73 (82) |
| Elevated GGT/ALP | 1/24 (4) | 16/35 (46) | 62/75 (83) |
| Acute pancreatitis (AP) | - | 0/3 | 18/23 (78) |
| AP in the anamnesis | 1/12 (8) | 0/3 | 3/5 (60) |
| Jaundice in the anamnesis | 0/27 | 1/2 (50) | - |
| US: CBD ≥ 8 mm | 0/7 | 6/11 (55) | 32/35 (91) |
| US: bile duct stone | 0/1 | - | 4/6 (67) |
- Citation: Lakatos L, Mester G, Reti G, Nagy A, Lakatos PL. Selection criteria for preoperative endoscopic retrograde cholangiopancreatography before laparoscopic cholecystectomy and endoscopic treatment of bile duct stones: Results of a retrospective, single center study between 1996-2002. World J Gastroenterol 2004; 10(23): 3495-3499
- URL: https://www.wjgnet.com/1007-9327/full/v10/i23/3495.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i23.3495